EyePoint Pharmaceuticals
EYPT
EYPT
61 hedge funds and large institutions have $97.2M invested in EyePoint Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+4
Holders Change %
+7.02%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
21
Reduced
12
Closed
8
Calls
$211K
Puts
$143K
Net Calls
+$68K
Net Calls Change
-$38K
Top Buyers
| 1 |
BlackRock
New York
|
$7.81M |
| 2 |
State Street
Boston,
Massachusetts
|
$1.71M |
| 3 |
GC
Grimes & Company
Westborough,
Massachusetts
|
$153K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$968K |
| 5 |
Morgan Stanley
New York
|
$556K |
